Freshfields Bruckhaus Deringer has come under scrutiny for its role on an acquisition by China’s Alibaba that has fallen foul of Hong Kong’s takeover regulator.
The Takeovers and Mergers Panel of Hong Kong Securities and Futures Commission found that the e-commerce giant had breached the territory’s takeover rules when it bought a healthcare company in 2014, because the acquisition amounted to a “special deal”, prohibited under the code.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
